Amneal Pharma <AMRX.O>: Oppenheimer Initiates Coverage With Outperform Rating; Price Target $27
AMRX•Related News
Quanome signs US$18.8 million deal to buy NVIDIA-powered AI computing infrastructure
QNME•
Passive investing? That S&P 500 index fund is basically a tech fund: McGeever
SPY•
American Rebel unit Champion Safe launches lean overhaul at Utah factory to lift throughput
AREB•
Core AI Holdings flags Nasdaq notice on minimum shareholders’ equity shortfall
CHAI•
Cintas' Q1 revenue, adj EPS beat estimates, outlook raised
CTAS•